Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Free Cash Flow of $43.7 million for Q1 2026, up 56.74% year-over-year from $27.9 million in Q1 2025, and up 77.57% quarter-over-quarter from $24.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Free Cash Flow history runs 14 years deep, the most recent figure standing at $43.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 56.74% year-over-year to $43.7 million; the TTM figure through Mar 2026 stood at $137.0 million (down 10.84% YoY), while the FY2025 annual figure was $121.2 million, down 29.66% from the prior year.
- Free Cash Flow for Q1 2026 stood at $43.7 million, up from $24.6 million in the prior quarter.
- The five-year high for Free Cash Flow was $71.2 million in Q2 2024, with the low at -$6.9 million in Q4 2024.
- The 5-year median for Free Cash Flow is $36.8 million (2025), against an average of $35.3 million.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 1879.94% in 2023, then slumped 114.33% in 2024.
- Amphastar Pharmaceuticals' Free Cash Flow stood at $13.4 million in 2022, then soared by 259.18% to $48.1 million in 2023, then plunged by 114.33% to -$6.9 million in 2024, then surged by 456.55% to $24.6 million in 2025, then surged by 77.57% to $43.7 million in 2026.
- Business Quant data shows AMPH's Free Cash Flow at $43.7 million in Q1 2026, $24.6 million in Q4 2025, and $32.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | 42.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.73 Mn |
| Jun 30, 2026 | 42.73 Mn |
| Mar 31, 2026 | 43.67 Mn |
| Mar 31, 2026 | 43.67 Mn |
| Dec 31, 2025 | 24.59 Mn |
| Dec 31, 2025 | 24.59 Mn |
| Sep 30, 2025 | 32.03 Mn |
| Sep 30, 2025 | 32.03 Mn |
| Jun 30, 2025 | 36.76 Mn |
| Jun 30, 2025 | 36.76 Mn |
| Mar 31, 2025 | 27.86 Mn |
| Mar 31, 2025 | 27.86 Mn |
| Dec 31, 2024 | -6.90 Mn |
| Dec 31, 2024 | -6.90 Mn |
| Sep 30, 2024 | 61.57 Mn |
| Sep 30, 2024 | 61.57 Mn |
| Jun 30, 2024 | 71.17 Mn |
| Jun 30, 2024 | 71.17 Mn |
| Mar 31, 2024 | 46.50 Mn |
| Mar 31, 2024 | 46.50 Mn |